Citizens analyst Jason Butler reiterated a Market Outperform rating and $131.00 price target on Abivax (NASDAQ: ABVX).The analyst commented, "Obefazimod ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE